| News & Announcements | Expanded Coverage of 20-Valent Pneumococcal Conjugate Vaccine for Independence Commercial Members (Retroactively Effective June 27, 2023) | | | | | | 10/10/2023 | | | |
| News & Announcements | Coverage of the COVID-19 Vaccination for Independence Commercial Members (Updated on October 12, 2023. Retroactively Effective to October 3, 2023.) | | | | | | 10/12/2023 | | | |
| News & Announcements | Coverage of Respiratory Syncytial Virus Immunizations for Independence Commercial Members (Updated October 18, 2023; Retroactively Effective October 6, 2023) | | | | | | 10/16/2023 | | | |
| Notifications | Preventive Care Services | 00.06.02ao | 10/3/2023 10:00 AM | 1/1/2024 | | | 10/3/2023 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding | | |
| Notifications | Wound Care: Skin Substitutes for the Treatment of Burns and Chronic, Non-Healing Wounds | 11.08.20ai | 10/20/2023 2:00 PM | 1/1/2024 | | | 10/20/2023 | Medical Coding;General Description, Guidelines, or Informational Update | | |
| Notifications | Wheelchair Options and Accessories | 05.00.67s | 10/21/2023 11:00 AM | 11/20/2023 | | | 10/21/2023 | Coverage and/or Reimbursement Position;Medical Coding | | |
| Notifications | Negative Pressure Wound Therapy Systems | 05.00.38m | 10/24/2023 12:00 PM | 1/22/2024 | | | 10/24/2023 | Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| New Policies | rozanolixizumab-noli (Rystiggo) | 08.02.08 | | 10/9/2023 | | | 10/9/2023 | This is a New Policy. | | |
| New Policies | Nadofaragene Firadenovec-vncg (Adstiladrin®) | 08.02.11 | | 9/11/2023 | | | 10/11/2023 | This is a New Policy. | | |
| New Policies | Glofitamab-gxbm (Columvi) | 08.02.07 | | 10/23/2023 | | | 10/23/2023 | This is a New Policy. | | |
| New Policies | Valoctocogene roxaparvovec-rvox (ROCTAVIAN™) | 08.02.09 | | 10/23/2023 | | | 10/23/2023 | This is a New Policy. | | |
| Updated Policies | Transcatheter Cardiac Valve Procedures | 11.02.25h | | 10/1/2023 | | | 10/2/2023 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Radiation Therapy Services (Independence) | 09.00.56q | | 10/1/2023 | | | 10/2/2023 | Medical Necessity Criteria | | |
| Updated Policies | Modifier 25: Significant, Separately Identifiable Evaluation and Management Service by the Same Physician or Other Qualified Health Care Professional on the Same Day of the Procedure or Other Service | 03.00.06x | 6/19/2023 2:00 PM | 10/2/2023 | | | 10/2/2023 | Coverage and/or Reimbursement Position;Medical Coding | | |
| Updated Policies | Efgartigimod alfa - fcab (Vyvgart) and efgartigimod alfa and hyaluronidase-qvfc (Vyvgart Hytrulo) | 08.01.84b | | 10/9/2023 | | | 10/9/2023 | Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Lipectomy and Liposuction | 11.08.03m | | 10/9/2023 | | | 10/9/2023 | Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Intravitreal Injection of Vascular Endothelial Growth Factor (VEGF) Antagonists and Related Biosimilars | 08.00.74t | | 10/16/2023 | | | 10/16/2023 | Medical Necessity Criteria | | |
| Updated Policies | Mogamulizumab-kpkc (Poteligeo®) | 08.01.52e | | 10/23/2023 | | | 10/23/2023 | Medical Necessity Criteria;Medical Coding | | |
| Updated Policies | Always Bundled Procedure Codes | 00.01.52t | | 10/23/2023 | | | 10/23/2023 | Coverage and/or Reimbursement Position | | |
| Updated Policies | Chimeric Antigen Receptor (CAR) Therapy | 08.01.43l | | 10/23/2023 | | | 10/23/2023 | Medical Necessity Criteria | | |
| Updated Policies | Loncastuximab tesirine-lpyl (Zynlonta®) | 08.00.59c | | 10/23/2023 | | | 10/23/2023 | Medical Necessity Criteria | | |
| Updated Policies | Gonadotropin-Releasing Hormone Agonist (Camcevi™, Eligard®, Fensolvi®, Lupron Depot®) | 08.01.33i | | 10/23/2023 | | | 10/23/2023 | Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Golimumab (Simponi Aria®) Intravenous (IV) Injection | 08.01.15g | 8/1/2023 10:00 AM | 10/30/2023 | | | 10/30/2023 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding | | |
| Reissue Policies | In Vivo Allergy Sensitivity Testing | 07.00.05i | | 12/5/2022 | 10/4/2023 | | 10/4/2023 | | | |
| Reissue Policies | Chiropractic Spinal and Extraspinal Manipulation Therapy | 10.02.02j | | 5/18/2020 | 10/4/2023 | | 10/4/2023 | | | |
| Reissue Policies | Allergy Immunotherapy | 07.00.21i | | 1/1/2021 | 10/4/2023 | | 10/4/2023 | | | |
| Reissue Policies | Ustekinumab (Stelara®) | 08.00.82n | | 10/24/2022 | 10/4/2023 | | 10/4/2023 | | | |
| Reissue Policies | In Vitro Allergy Testing | 06.02.26e | | 12/19/2022 | 10/4/2023 | | 10/4/2023 | | | |
| Reissue Policies | Compression Garments | 05.00.37g | | 4/1/2023 | 10/4/2023 | | 10/4/2023 | | | |
| Reissue Policies | Bioimpedance for the Detection of Lymphedema | 07.06.03b | | 12/29/2014 | 9/20/2023 | | 10/6/2023 | | | 10/6/2023 |
| Reissue Policies | Etranacogene dezaparvovec-drlb (Hemgenix ®) | 08.02.03 | | 5/22/2023 | 10/4/2023 | | 10/9/2023 | | | |
| Reissue Policies | Bioimpedance for the Detection of Lymphedema | 07.06.03b | | 12/29/2014 | 9/20/2023 | | 10/9/2023 | | | |
| Reissue Policies | Artificial Intervertebral Lumbar Disc Insertion | 11.15.31b | | 1/1/2023 | 10/18/2023 | | 10/18/2023 | | | |
| Reissue Policies | Ovarian and Internal Iliac Vein Embolization as Treatment for Pelvic Congestion Syndrome | 11.06.07d | | 4/23/2018 | 10/18/2023 | | 10/18/2023 | | | |
| Reissue Policies | Electromyography (EMG) Studies: Needle EMG, Surface EMG (SEMG) | 07.03.09u | | 10/1/2023 | 10/18/2023 | | 10/18/2023 | | | |
| Reissue Policies | Brachytherapy and Accelerated Whole Breast Irradiation using Three-Dimensional Conformation Radiation Therapy | 09.00.10z | | 7/15/2019 | 10/18/2023 | | 10/18/2023 | | | |
| Reissue Policies | Electroconvulsive Therapy (ECT) | 14.00.01a | | 10/1/2023 | 10/18/2023 | | 10/18/2023 | | | |
| Reissue Policies | Nerve Conduction Studies (NCS) and Related Electrodiagnostic Studies | 07.03.18t | | 10/1/2023 | 10/18/2023 | | 10/18/2023 | | | |
| Coding Update | Prophylactic Mastectomy, Oophorectomy/Salpingo-Oophorectomy, and Hysterectomy | 11.08.19q | | 10/1/2023 | | | 10/2/2023 | | | |
| Coding Update | Prescription Digital Therapeutics and Mobile-Based Health Management Applications | 12.00.05a | | 10/1/2023 | | | 10/2/2023 | | | |
| Coding Update | Preventive Care Services | 00.06.02an | | 10/1/2023 | | | 10/2/2023 | | | |
| Coding Update | Modifier 62: Two Surgeons | 00.10.11w | | 10/1/2023 | | | 10/4/2023 | | | |
| Coding Update | Modifier 50: Bilateral Procedure | 03.00.05v | | 10/1/2023 | | | 10/4/2023 | | | |
| Coding Update | Modifier 25: Significant, Separately Identifiable Evaluation and Management Service by the Same Physician or Other Qualified Health Care Professional on the Same Day of the Procedure or Other Service | 03.00.06y | | 10/1/2023 | | | 10/5/2023 | | | |
| Coding Update | Mohs Micrographic Surgery | 11.08.23k | | 10/1/2023 | | | 10/6/2023 | | | 10/6/2023 |
| Coding Update | Reimbursement for Associated Services Performed in Conjunction with Dental Care | 00.01.18g | | 10/1/2023 | | | 10/6/2023 | | | |
| Coding Update | Mohs Micrographic Surgery | 11.08.23k | | 10/1/2023 | | | 10/9/2023 | | | |
| Coding Update | Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)/(Abraxane® for Injectable Suspension) | 08.00.90o | | 7/1/2023 | | | 10/9/2023 | | | |
| Coding Update | Pemetrexed (Alimta®), Pemetrexed (Pemfexy™) | 08.00.87l | | 7/1/2023 | | | 10/9/2023 | | | |
| Coding Update | Teclistamab-cqyv (Tecvayli™) | 08.01.98b | | 7/1/2023 | | | 10/9/2023 | | | |
| Coding Update | Services Paid Above Capitation for Health Maintenance Organization (HMO) and Health Maintenance Organization Point-of-Service (HMO-POS) Primary Care Providers | 00.10.01aj | | 10/1/2023 | 10/1/2023 | | 10/18/2023 | | | |
| Coding Update | PPO Network Rules for Provision of Specialty Services for Durable Medical Equipment and Laboratory, Radiology, and Physical Medicine and Rehabilitative Services | 00.01.25bl | | 10/1/2023 | | | 10/20/2023 | | | |
| Coding Update | Magnetic Resonance Imaging (MRI) Contrast Agents | 09.00.45k | | 10/1/2023 | | | 10/24/2023 | | | |
| Coding Update | Reimbursement for Radiopharmaceutical Agents for Professional Providers | 09.00.32ad | | 10/1/2023 | | | 10/24/2023 | | | |
| Coding Update | Laboratory Services for Members Enrolled in Health Maintenance Organization (HMO) or Health Maintenance Organization Point-of-Service (HMO-POS) Products | 00.03.07al | | 10/1/2023 | 10/1/2023 | | 10/27/2023 | | | |